EGFR and non-small cell lung carcinoma: Here, we evaluated whether long-term exposure to low-dose curcumin affected the response of cells to the chemotherapy agents, cisplatin and pemetrexed, used as first-line chemotherapy in NSCLC of non-squamous histology with no known EGFR sensitising mutation, and also at relapse for those with EGFR mutation.